Carcinoma, Renal Cell: all 1,992 studies
Page 17 of 20. Open to participants first (387), then studies with results posted, then the rest; newest registration first within each.
- Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaCompletedNCT01339975
- Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.CompletedNCT01339962
- Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney CancerTerminatedNCT01336231
- Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid TumorsCompletedNCT01334073Phase 1
- Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor ThrombusCompletedNCT01328691
- Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular CarcinomaTerminatedNCT01326390
- Dendritic Cell Vaccination for Patients with Solid TumorsCompletedNCT01291420Phase 1/2
- Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell CarcinomaCompletedNCT01283048Phase 1
- Fluorescence Imaging in Finding Tumors in Patients With Kidney TumorsCompletedNCT01281488Phase 1
- Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney CancerStatus unknownNCT01274273Phase 2
- Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)CompletedNCT01266837Phase 4
- IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell CarcinomaCompletedNCT01265901Phase 3
- Caphosol in Oral Mucositis Due to Targeted TherapyCompletedNCT01265810Phase 3
- A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET)CompletedNCT01265368Phase 1/2
- Novel Peptide Vaccination for Patients With Advanced Renal Cell CarcinomaCompletedNCT01254838Phase 1
- Evaluation of Cognitive Function of Patients With Sunitinib or SorafenibCompletedNCT01246843
- Temsirolimus-RCC-imagingStatus unknownNCT01246817Phase 2
- Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid MalignanciesCompletedNCT01243359Phase 1
- Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell CarcinomaStatus unknownNCT01240005Phase 1/2
- Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)Status unknownNCT01230697
- The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell CarcinomaCompletedNCT01227213
- Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) ScrambleActive, not recruitingNCT01224288Phase 3
- Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)CompletedNCT01221506Early Phase 1
- Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell CarcinomaStatus unknownNCT01219751Phase 2
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START TrialActive, not recruitingNCT01217931Phase 2
- Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)TerminatedNCT01216371Phase 2
- Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid TumorsCompletedNCT01202032Phase 1
- Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid TumorsCompletedNCT01198184Phase 1
- Hepatic and Renal Thermography Using Magnetic Resonance ImagingTerminatedNCT01197820Not applicable
- Advanced Renal Cell Carcinoma, With Failure or Unsuitable on Prior Interferon-alpha or Interleukin-2 Based TherapyTerminatedNCT01195649
- Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) PatientsCompletedNCT01182142Phase 2
- Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal CancerCompletedNCT01176552Phase 2
- A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid TumorsWithdrawnNCT01176500Phase 1/2
- Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell CarcinomaCompletedNCT01173445
- Heated Chemotherapy for Cancers That Have Spread to the Chest CavityCompletedNCT01163552Phase 2
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- Safety of RAD001 in Chinese Patients With Metastatic Renal Cell CancerCompletedNCT01152801Phase 1
- Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell CarcinomaTerminatedNCT01144169Phase 1
- Contrast-enhanced Ultrasound for Follow-up After Radiofrequency Ablation of Kidney LesionsStatus unknownNCT01141816Not applicable
- B-Receptor Signaling in CardiomyopathyCompletedNCT01135849
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
- Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)CompletedNCT01122615Phase 1
- A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney CancerCompletedNCT01114230Phase 1
- Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of BiomarkersCompletedNCT01107509Not applicable
- Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney CancerStatus unknownNCT01105364Not applicable
- A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid TumorsCompletedNCT01100619Phase 1
- Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney CancerStatus unknownNCT01099423Phase 3
- Detection of Renal Malignancy of Complicated Renal CystsCompletedNCT01087060
- Study of Nelfinavir and Temsirolimus in Patients With Advanced CancersCompletedNCT01079286Phase 1
- Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino PatientsTerminatedNCT01073644
- Study of Sunitinib in Subjects With High Risk Renal Cell CarcinomaWithdrawnNCT01070186Phase 2
- Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)Status unknownNCT01069770Phase 2
- Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 TherapyTerminatedNCT01068470
- A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell CarcinomaTerminatedNCT01063998
- Efficacy of Ultrasound Contrast Agent to Assess Renal MassesCompletedNCT01062178Phase 2
- Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01061411Phase 1
- A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell CarcinomaStatus unknownNCT01041482Phase 2
- Sunitinib in Metastatic Renal CancerCompletedNCT01034878Phase 2
- Cost Effectiveness Of Sunitinib In Central America And CaribbeanTerminatedNCT01033981
- Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell CarcinomaCompletedNCT01028638
- Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney CancerCompletedNCT01026337
- Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney CancerCompletedNCT01024205Phase 2
- A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell CancerCompletedNCT01021059Phase 1
- A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell CarcinomaCompletedNCT01015911Phase 1
- A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)CompletedNCT01014065
- Regulatory Post Marketing Surveillance Study on Nexavar®CompletedNCT01012011
- Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung CancersCompletedNCT01005797Phase 1
- Novel Prognostic Markers in Renal CancerCompletedNCT01002937
- A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family MembersStatus unknownNCT00994188Not applicable
- An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell CarcinomaCompletedNCT00992121Phase 1
- Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in FinlandCompletedNCT00980213
- Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus SunitinibCompletedNCT00979966Phase 2
- Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase InhibitorCompletedNCT00979381
- Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GISTCompletedNCT00979329
- Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell CarcinomaTerminatedNCT00953446Not applicable
- Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell CarcinomaStatus unknownNCT00945984
- Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)CompletedNCT00944905Phase 1
- Sunitinib Malate in Treating Patients With Kidney CancerCompletedNCT00943839Not applicable
- Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell CancerTerminatedNCT00942058
- Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerTerminatedNCT00937482Phase 1
- Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaTerminatedNCT00930345Phase 4
- Clinical Trial to Assess the Importance of NephrectomyCompletedNCT00930033Phase 3
- Study Evaluating Renal Cell Carcinoma Risk FactorsCompletedNCT00927043
- A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced MalignanciesCompletedNCT00923520Phase 1
- Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 ReceptorTerminatedNCT00923390Phase 1
- Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)CompletedNCT00923169Phase 1
- Cryoablation Versus Radiofrequency Ablation for Small Renal MassesWithdrawnNCT00922948Phase 2
- Follow-up After Metastasectomy in Patients With Kidney CancerActive, not recruitingNCT00918775Phase 2
- Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney CancerWithdrawnNCT00908739
- DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCECompletedNCT00900536
- Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy ParticipantsCompletedNCT00900276
- SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney CancerCompletedNCT00900042
- Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney CancerTerminatedNCT00899860
- Study of Kidney Tumors in Younger PatientsCompletedNCT00898365
- Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With NexavarCompletedNCT00895674
- Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00891475Phase 1/2
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With SunitinibStatus unknownNCT00890110Phase 1/2
- An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037CompletedNCT00884520Early Phase 1
- Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell CarcinomaCompletedNCT00876382